Immunome, Inc. (IMNM) Misses Q3 EPS by 8c

Immunome, Inc. (NASDAQ: IMNM) reported Q3 EPS of ($0.65), $0.08 worse than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance